The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
PHASE II DRUG METABOLIZING ENZYMES
Open accessAbstract
BACKGROUND: Phase II biotransformation reactions (also 'conjugation reactions') generally serve as a detoxifying step in drug metabolism. Phase II drug metabolising enzymes are mainly transferases. This review covers the major phase II enzymes: UDP-glucuronosyltransferases, sulfotransferases, N-acetyltransferases, glutathione S-transferases and methyltransferases (mainly thiopurine S-methyl transferase and catechol O-methyl transferase). The focus is on the presence of various forms, on tissue and cellular distribution, on the respective substrates, on genetic polymorphism and finally on the interspecies differences in these enzymes. METHODS AND RESULTS: A literature search using the following databases PubMed, Science Direct and EBSCO for the years, 1969-2010. CONCLUSIONS: Phase II drug metabolizing enzymes play an important role in biotransformation of endogenous compounds and xenobiotics to more easily excretable forms as well as in the metabolic inactivation of pharmacologically active compounds. Reduced metabolising capacity of Phase II enzymes can lead to toxic effects of clinically used drugs. Gene polymorphism/ lack of these enzymes may often play a role in several forms of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544
SHEEHAN, D., MEADE, G., FOLEY, V. M., & DOWD, C. A. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600001 · Cited by 3,057
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Structure, Catalytic Mechanism, and Evolution of the Glutathione Transferases
Armstrong, R. N. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960072x · Cited by 1,143
Glutathione S-Transferase Polymorphisms and Their Biological Consequences
Hayes, J. D., & Strange, R. C. (2000) · Pharmacology · doi:10.1159/000028396 · Cited by 1,001
Cytochromes P450 and metabolism of xenobiotics
Anzenbacher, P., & Anzenbacherová, E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000897 · Cited by 889
Self-citationNomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S.-I., Iyanagi, T., Miners, J. O., Owens, I. S., & Nebert, D. W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000173483.13689.56 · Cited by 821
Human Sulfotransferases and Their Role in Chemical Metabolism
Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj061 · Cited by 703
UDP-glucuronosyltransferases and clinical drug-drug interactions
KIANG, T., ENSOM, M., & CHANG, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.013 · Cited by 552
Sulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487
King, C., Rios, G., Green, M., & Tephly, T. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339171 · Cited by 432
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
Guillemette, C. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500171 · Cited by 425
Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408
Kadakol, A., Ghosh, S. S., Sappal, B. S., Sharma, G., Chowdhury, J. R., & Chowdhury, N. R. (2000) · Human Mutation · doi:10.1002/1098-1004(200010)16:4<297::aid-humu2>3.0.co;2-z · Cited by 387
The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†
Fisher, M. B., Paine, M. F., Strelevitz, T. J., & Wrighton, S. A. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000653 · Cited by 375
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369
Sulfotransferases in the bioactivation of xenobiotics
Glatt, H. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00202-7 · Cited by 354
Glatt, S. J., Faraone, S. V., & Tsuang, M. T. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.469 · Cited by 344
Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency
Arias, I. M., Gartner, L. M., Cohen, M., Ezzer, J. B., & Levi, A. J. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90224-1 · Cited by 340
Coffman, B. L., King, C. D., Rios, G. R., & Tephly, T. R. (1998) · PubMed · Cited by 322
Developmental aspects of human hepatic drug glucuronidation in young children and adults
Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., & Manns, M. P. (2002) · Gut · doi:10.1136/gut.50.2.259 · Cited by 288
GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE
Wells, P. G., Mackenzie, P. I., Roy Chowdhury, J., Guillemette, C., Gregory, P. A., Ishii, Y., Hansen, A. J., Kessler, F. K., Kim, P. M., Roy Chowdhury, N., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.281 · Cited by 260
Uchaipichat, V., Mackenzie, P. I., Elliot, D. J., & Miners, J. O. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007369 · Cited by 248
Grant, D. M., Blum, M., Beer, M., & Meyer, U. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10988-7 · Cited by 246
Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.
Weinshilboum, R. M. (2001) · PubMed · Cited by 238
Tukey, R. H., & Strassburg, C. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12228-6 · Cited by 237
Miners, J. O., Knights, K. M., Houston, J. B., & Mackenzie, P. I. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.019 · Cited by 228
Glutathione conjugation as a bioactivation reaction
van Bladeren, P. J. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00214-3 · Cited by 226
Specificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidation
Burchell, B., Brierley, C. H., & Rance, D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02073-r · Cited by 224
Szumlanski, C., & Weinshilboum, R. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04478.x · Cited by 223
Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase
Falany, C. N., Krasnykh, V., & Falany, J. L. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00015-r · Cited by 220
Pharmacogenetics of Sulfotransferase
Nagata, K., & Yamazoe, Y. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.159 · Cited by 215
Tiihonen, J., Hallikainen, T., Lachman, H., Saito, T., Volavka, J., Kauhanen, J., Salonen, J. T., Ryynänen, O.-P., Koulu, M., Karvonen, M. K., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000509 · Cited by 189
Morel, F., Rauch, C., Petit, E., Piton, A., Theret, N., Coles, B., & Guillouzo, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313357200 · Cited by 179
Uchaipichat, V., Winner, L. K., Mackenzie, P. I., Elliot, D. J., Williams, J. A., & Miners, J. O. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02588.x · Cited by 178
Diversity and functions of glycosaminoglycan sulfotransferases
Habuchi, O. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00016-7 · Cited by 173
Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases
Li, Y., Lindsay, J., Wang, L.-L., & Zhou, S.-F. (2008) · Current Drug Metabolism · doi:10.2174/138920008783571819 · Cited by 167
King, C. D., Rios, G. R., Assouline, J. A., & Tephly, T. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1155 · Cited by 165
X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3
Dajani, R., Cleasby, A., Neu, M., Wonacott, A. J., Jhoti, H., Hood, A. M., Modi, S., Hersey, A., Taskinen, J., Cooke, R. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37862 · Cited by 158
Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.
Cheng, Z., Radominska-p, A., & Tephly, T. R. (1999) · PubMed · Cited by 154
Pharmacogenetics of soluble sulfotransferases (SULTs)
Glatt, H. R., & Meinl, W. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0826-0 · Cited by 153
Shield, A., Thomae, B. A., Eckloff, B. W., Wieben, E. D., & Weinshilboum, R. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001386 · Cited by 153
Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Agúndez, J. A. G. (2008) · Current Drug Metabolism · doi:10.2174/138920008784892083 · Cited by 142
Inhibition of Sulfotransferases by Xenobiotics
Wang, L., & James, M. O. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832596 · Cited by 139
Bilirubin metabolism: Applied physiology
Wang, X., Chowdhury, J. R., & Chowdhury, N. R. (2006) · Current Paediatrics · doi:10.1016/j.cupe.2005.10.002 · Cited by 136
Javitt, N. B., Lee, Y. C., Shimizu, C., Fuda, H., & Strott, C. A. (2001) · Endocrinology · doi:10.1210/endo.142.7.8244 · Cited by 132
Fetal hepatic drug elimination
Ring, J. A., Ghabrial, H., Ching, M. S., Smallwood, R. A., & Morgan, D. J. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00046-7 · Cited by 131
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Hearse, D. J., & Weber, W. W. (1973) · Biochemical Journal · doi:10.1042/bj1320519 · Cited by 129
Kunugi, H., Nanko, S., Ueki, A., Otsuka, E., Hattori, M., Hoda, F., Vallada, H., Arranz, M. J., & Collier, D. A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13289-4 · Cited by 128
Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain
Falany, C. N., Xie, X., Wang, J., FERRER, J., & Falany, J. L. (2000) · Biochemical Journal · doi:10.1042/bj3460857 · Cited by 127
Cloning and expression of human liver dehydroepiandrosterone sulphotransferase
Comer, K. A., Falany, J. L., & Falany, C. N. (1993) · Biochemical Journal · doi:10.1042/bj2890233 · Cited by 120
Otterness, D. M., Szumlanski, C. L., Wood, T. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1004 · Cited by 118
Watanabe, M., Sofuni, T., & Nohmi, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42462-3 · Cited by 116
Regulation of UDP glucuronosyltransferases in the gastrointestinal tract
Gregory, P. A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.008 · Cited by 115
UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term
Collier, A. C., Ganley, N. A., Tingle, M. D., Blumenstein, M., Marvin, K. W., Paxton, J. W., Mitchell, M. D., & Keelan, J. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00890-5 · Cited by 111
Ulmanen, I., Peränen, J., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., Bernasconi, L., Aubry, J., & Lundstrom, K. H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0452a.x · Cited by 108
Eukaryotic arylamine N-acetyltransferase
Kawamura, A., Graham, J. W. A., Mushtaq, A., Tsiftsoglou, S. A., Vath, G. M., Hanna, P. E., Wagner, C. R., & Sim, E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.014 · Cited by 108
Dajani, R., Hood, A. M., & Coughtrie, M. W. H. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.942 · Cited by 99
Kauhanen, J., Hallikainen, T., Tuomainen, T., Koulu, M., Karvonen, M. K., Salonen, J. T., & Tiihonen, J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04582.x · Cited by 96
Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase
Mackenzie, P. I., Rogers, A., Treloar, J., Jorgensen, B. R., Miners, J. O., & Meech, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807961200 · Cited by 96
Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
Cheng, Z., Radominska-p, A., & Tephly, T. R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15041-6 · Cited by 93
Fujita, K., Nagata, K., Ozawa, S., Sasano, H., & Yamazoe, Y. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021846 · Cited by 90
Jinno, H., Saeki, M., Saito, Y., Tanaka‐Kagawa, T., Hanioka, N., Sai, K., Kaniwa, N., Ando, M., Shirao, K., Minami, H., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051250 · Cited by 87
Pharmacogenetics of the ArylamineN-Acetyltransferases: A Symposium in Honor of Wendell W. Weber
Hein, D. W., McQueen, C. A., Grant, D. M., GOODFELLOW, G. H., Kadlubar, F. F., & Weber, W. W. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)13670-7 · Cited by 85
Pharmacokinetics and Molecular Detoxication
Cashman, J. R., Perotti, B. Y. T., Berkman, C. E., & Lin, J. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s123 · Cited by 84
Tissue-specific expression of rat sulfotransferase messenger RNAs.
Dunn, R. T., & Klaassen, C. D. (1998) · PubMed · Cited by 82
Wang, T., Franke, P. E., Neidt, H., Cichon, S., Knapp, M., Lichtermann, D., Maier, W., Propping, P., & Nöthen, M. M. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000803 · Cited by 74
Soboll, S., GRÜNDEL, S., Harris, J. M., Kolb-Bachofen, V., KETTERER, B., & Sies, H. (1995) · Biochemical Journal · doi:10.1042/bj3110889 · Cited by 73
Lammer, E. J., Shaw, G. M., Iovannisci, D. M., & Finnell, R. H. (2004) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20081 · Cited by 73
Wang, P. C., Buu, N. T., Kuchel, O., & Genest, J. (1983) · PubMed · Cited by 72
Sneitz, N., Court, M. H., Zhang, X., Laajanen, K., Yee, K. K., Dalton, P., Ding, X., & Finel, M. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283330767 · Cited by 71
Court, M. H., Hazarika, S., Krishnaswamy, S., Finel, M., & Williams, J. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045500 · Cited by 66
Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9
Chen, Y., Xie, S., Chen, S., & Zeng, S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.007 · Cited by 64
Meinl, W., Meerman, J. H. N., & Glatt, H. R. (2002) · Pharmacogenetics · doi:10.1097/00008571-200212000-00002 · Cited by 63
Taskinen, J., Ethell, B. T., Pihlavisto, P., Hood, A. M., Burchell, B., & Coughtrie, M. W. H. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1187 · Cited by 63
Sakakibara, Y., Suiko, M., Pai, T. G., Nakayama, T., Takami, Y., Katafuchi, J., & Liu, M. (2002) · Gene · doi:10.1016/s0378-1119(02)00431-6 · Cited by 61
Antonini, A., Abbruzzese, G., Barone, P., Bonuccelli, U., Lopiano, L., Onofrj, M., Zappia, M., & Quattrone, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2404 · Cited by 60
Pai, T. G., Sugahara, T., Suiko, M., Sakakibara, Y., Xu, F., & Liu, M. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00416-6 · Cited by 54
Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan
Yoritaka, A., Hattori, N., Yoshino, H., & Mizuno, Y. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294732 · Cited by 54
Caraco, Y., Sheller, J. R., & Wood, A. J. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36560-7 · Cited by 54
Induction of Human Arylamine N -Acetyltransferase Type I by Androgens in Human Prostate Cancer Cells
Butcher, N. J., Tetlow, N., Cheung, C. W. Y., Broadhurst, G. M., & Minchin, R. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2635 · Cited by 54
Genistein Induction of Human Sulfotransferases in HepG2 and Caco‐2 Cells
Chen, Y., Huang, C., Zhou, T., & Chen, G. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00316.x · Cited by 52
Chen, G. W., Chung, J., Hsieh, C. L., & Lin, J.-H. (1998) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(98)00046-5 · Cited by 52
Inter-species differences in drug properties
Collins, J. M. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00158-2 · Cited by 50
Krishnaswamy, S., Duan, S., Moltke, L. L., et al. (2003) · Xenobiotica · doi:10.1080/0049825021000048809 · Cited by 50
Senggunprai, L., Yoshinari, K., & Yamazoe, Y. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027441 · Cited by 48
Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1
Kawamura, A., Westwood, I. M., Wakefield, L., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.12.012 · Cited by 46
Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)∗
Li, X., Clemens, D. L., & Anderson, R. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00475-5 · Cited by 42
Yoshinari, K., Nagata, K., Ogino, M., Fujita, K., Shiraga, T., Iwasaki, K., Hata, T., & Yamazoe, Y. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021961 · Cited by 41
Vietri, M., Pietrabissa, A., Mosca, F., Spisni, R., & Pacifici, G. M. (2003) · Xenobiotica · doi:10.1080/0049825031000065197 · Cited by 40
Tsoi, C., Falany, C. N., Morgenstern, R., & Swedmark, S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560891 · Cited by 40
Molecular characterization of ST1C1-related human sulfotransferase
Yoshinari, K. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.951 · Cited by 40
Inhibitory effects of polyphenolic compounds on human arylamineN-acetyltransferase 1 and 2
Kukongviriyapan, V., Phromsopha, N., Tassaneeyakul, W., Kukongviriyapan, U., Sripa, B., Hahnvajanawong, V., & Bhudhisawasdi, V. (2006) · Xenobiotica · doi:10.1080/00498250500489901 · Cited by 40
Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia
Park, T., Yoon, K., Kim, J. H., Park, W., Hirvonen, A., & Kang, D. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00030-5 · Cited by 40
Bioactivation of benzylic and allylic alcohols via sulfo-conjugation
Surh, Y. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00134-8 · Cited by 39
Wen, Z., Martin, D. E., Bullock, P. L., Lee, K., & Smith, P. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012815 · Cited by 38
All‐trans Retinoic Acid Induction of Sulfotransferases
Maiti, S., Chen, X., & Chen, G. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960107.x · Cited by 37
Lehmann, L., Jiang, L., & Wagner, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm235 · Cited by 37
King, R. J., Ghosh, A., & Wu, J. (2006) · Current Drug Metabolism · doi:10.2174/138920006778520615 · Cited by 35
Functional characterization of the human thiopurine S‐methyltransferase (TPMT) gene promoter
Fessing, M. Y., Krynetski, E. Y., Zambetti, G. P., & Evans, W. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2560510.x · Cited by 34
Walraven, J. M., Doll, M. A., & Hein, D. W. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108399 · Cited by 34
Molecular Cloning, Expression and Characterization of A Novel Mouse SULT6 Cytosolic Sulfotransferase
Takahashi, S., Sakakibara, Y., Mishiro, E., Kouriki, H., Nobe, R., Kurogi, K., Yasuda, S., Liu, M.-C., & Suiko, M. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp087 · Cited by 33
Ehmer, U., Lankisch, T. O., Erichsen, T. J., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080036 · Cited by 32
Williamson, G., DuPont, M. S., Wanigatunga, S., Heaney, R. K., Musk, S. R. R., Fenwick, G. R., & Rhodes, M. J. C. (1997) · Food Chemistry · doi:10.1016/s0308-8146(95)00255-3 · Cited by 27
Glucuronidation of bioflavonoids by human UGT1A10: structure–function relationships
Lewinsky, R., Smith, P. A., & Mackenzie, P. I. (2005) · Xenobiotica · doi:10.1080/00498250400028189 · Cited by 26
Feng, Q., Vannaprasaht, S., Peng, Y., Angsuthum, S., Avihingsanon, Y., Yee, V. C., Tassaneeyakul, W., & Weinshilboum, R. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.11.016 · Cited by 25
Arslan, S., Siliğ, Y., & Pınarbaşı, H. (2009) · Cell Biochemistry and Function · doi:10.1002/cbf.1558 · Cited by 21
Extract of Ginkgo biloba induces glutathione-S-transferase subunit-P1 in vitro
Liu, X., Goldring, C. E., Wang, H.-Y., Copple, I. M., Kitteringham, N. R., & Park, B. K. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.11.001 · Cited by 16
Cited by
Chemical transformation of xenobiotics by the human gut microbiota
Koppel, N., Maini Rekdal, V., & Balskus, E. P. (2017) · Science · doi:10.1126/science.aag2770 · Cited by 1,080
Cytochrome P450 Enzymes and Drug Metabolism in Humans
Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312808 · Cited by 1,070
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Alfarouk, K. O., Stock, C.-M., Taylor, S., Walsh, M., Muddathir, A. K., Verduzco, D., Bashir, A. H. H., Mohammed, O. Y., Elhassan, G. O., Harguindey, S., et al. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0221-1 · Cited by 665
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J., & Zhang, F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.09.003 · Cited by 617
Apoptosis and Necrosis in the Liver
Guicciardi, M. E., Malhi, H., Mott, J. L., & Gores, G. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120020 · Cited by 353
Metadata
- Authors
- Jancova, P., Anzenbacher, P., & Anzenbacherova, E.
- Venue
- Biomedical Papers
- Publisher
- Palacky University Olomouc
- Published
- 2010-06-01
- Volume
- 154
- Issue
- 2
- Pages
- 103-116
- ISSN
- 1213-8118 (ISSN-L)
- 1804-7521
- OpenAlex
- W2104243204
- Cited by
- 603
- References
- 112
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.